FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562467566> ?p ?o ?g. }

• W2562467566 endingPage "317" @default.
• W2562467566 startingPage "309" @default.
• W2562467566 abstract "Human islet transplantation is a viable treatment option for type 1 diabetes mellitus (T1DM). However, pancreatic islet inflammation after transplantation induced by innate immune responses is likely to hinder graft function. This is mediated by incompatibility between islets and the blood interface, known as instant blood-mediated inflammatory reaction (IBMIR). Herein we hypothesized that portal venous administration of islet cells with human recombinant antithrombin (ATryn ® ), a serine protease inhibitor (serpin), which plays a central role in the physiological regulation of coagulation and exerts indirect anti-inflammatory activities, may offset coagulation abnormalities such as disseminated intravascular coagulation (DIC) and IBMIR. The current prospective, randomized experiment was conducted using an established preclinical pig model. Three groups were constituted for digested pancreatic tissue transplantation (0.15 ml/kg): control, NaCl 0.9% ( n = 7); gold standard, heparin (25 UI/kg) ( n = 7); and human recombinant ATryn® (500 UI/kg) ( n = 7). Blood samples were collected over time (T0 to 24 h), and biochemical, coagulation, and inflammatory parameters were evaluated. In both the control and heparin groups, one animal died after a portal thrombosis, while no deaths occurred in the ATryn®-treated group. As expected, islet transplantation was associated with an increase in plasma IL-6 or TNF-α levels in all three groups. However, DIC was only observed in the control group, an effect that was suppressed after ATryn® administration. ATryn® administration increased antithrombin activity by 800%, which remained at 200% for the remaining period of the study, without any hemorrhagic complications. These studies suggest that coadministration of ATryn® and pancreatic islets via intraportal transplantation may be a valuable therapeutic approach for DIC without risk for islets and subjects." @default.
• W2562467566 created "2017-01-06" @default.
• W2562467566 creator A5002152162 @default.
• W2562467566 creator A5006759849 @default.
• W2562467566 creator A5052439704 @default.
• W2562467566 creator A5057395882 @default.
• W2562467566 creator A5058406910 @default.
• W2562467566 creator A5059080133 @default.
• W2562467566 creator A5059138998 @default.
• W2562467566 creator A5060610733 @default.
• W2562467566 creator A5064940562 @default.
• W2562467566 creator A5084330205 @default.
• W2562467566 creator A5087179037 @default.
• W2562467566 creator A5087652636 @default.
• W2562467566 date "2017-02-01" @default.
• W2562467566 modified "2023-10-18" @default.
• W2562467566 title "Human Recombinant Antithrombin (ATryn®) Administration Improves Survival and Prevents Intravascular Coagulation after Intraportal Islet Transplantation in a Piglet Model" @default.
• W2562467566 cites W1552445206 @default.
• W2562467566 cites W1752100137 @default.
• W2562467566 cites W1891400877 @default.
• W2562467566 cites W1917222344 @default.
• W2562467566 cites W1963505457 @default.
• W2562467566 cites W1975251263 @default.
• W2562467566 cites W1989989356 @default.
• W2562467566 cites W1992046160 @default.
• W2562467566 cites W2006894744 @default.
• W2562467566 cites W2012670984 @default.
• W2562467566 cites W2019584577 @default.
• W2562467566 cites W2024630021 @default.
• W2562467566 cites W2032203942 @default.
• W2562467566 cites W2036474812 @default.
• W2562467566 cites W2040605985 @default.
• W2562467566 cites W2047457251 @default.
• W2562467566 cites W2066808970 @default.
• W2562467566 cites W2068662272 @default.
• W2562467566 cites W2083090431 @default.
• W2562467566 cites W2086194193 @default.
• W2562467566 cites W2087284118 @default.
• W2562467566 cites W2104578077 @default.
• W2562467566 cites W2117195261 @default.
• W2562467566 cites W2128219297 @default.
• W2562467566 cites W2135337547 @default.
• W2562467566 cites W2137171012 @default.
• W2562467566 cites W2149138664 @default.
• W2562467566 cites W2155905771 @default.
• W2562467566 cites W2158844203 @default.
• W2562467566 cites W2163305657 @default.
• W2562467566 cites W2168128391 @default.
• W2562467566 cites W2238441516 @default.
• W2562467566 cites W2272987617 @default.
• W2562467566 cites W2277971551 @default.
• W2562467566 cites W2305612787 @default.
• W2562467566 cites W2310697230 @default.
• W2562467566 cites W2320283908 @default.
• W2562467566 cites W2345197321 @default.
• W2562467566 cites W2413986849 @default.
• W2562467566 cites W2415707997 @default.
• W2562467566 cites W255277696 @default.
• W2562467566 doi "https://doi.org/10.3727/096368916x693554" @default.
• W2562467566 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5657771" @default.
• W2562467566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27938471" @default.
• W2562467566 hasPublicationYear "2017" @default.
• W2562467566 type Work @default.
• W2562467566 sameAs 2562467566 @default.
• W2562467566 citedByCount "6" @default.
• W2562467566 countsByYear W25624675662018 @default.
• W2562467566 countsByYear W25624675662019 @default.
• W2562467566 countsByYear W25624675662020 @default.
• W2562467566 countsByYear W25624675662021 @default.
• W2562467566 countsByYear W25624675662023 @default.
• W2562467566 crossrefType "journal-article" @default.
• W2562467566 hasAuthorship W2562467566A5002152162 @default.
• W2562467566 hasAuthorship W2562467566A5006759849 @default.
• W2562467566 hasAuthorship W2562467566A5052439704 @default.
• W2562467566 hasAuthorship W2562467566A5057395882 @default.
• W2562467566 hasAuthorship W2562467566A5058406910 @default.
• W2562467566 hasAuthorship W2562467566A5059080133 @default.
• W2562467566 hasAuthorship W2562467566A5059138998 @default.
• W2562467566 hasAuthorship W2562467566A5060610733 @default.
• W2562467566 hasAuthorship W2562467566A5064940562 @default.
• W2562467566 hasAuthorship W2562467566A5084330205 @default.
• W2562467566 hasAuthorship W2562467566A5087179037 @default.
• W2562467566 hasAuthorship W2562467566A5087652636 @default.
• W2562467566 hasBestOaLocation W25624675661 @default.
• W2562467566 hasConcept C104317684 @default.
• W2562467566 hasConcept C126322002 @default.
• W2562467566 hasConcept C134018914 @default.
• W2562467566 hasConcept C165220095 @default.
• W2562467566 hasConcept C203014093 @default.
• W2562467566 hasConcept C2777557582 @default.
• W2562467566 hasConcept C2778382381 @default.
• W2562467566 hasConcept C2778442404 @default.
• W2562467566 hasConcept C2778734968 @default.
• W2562467566 hasConcept C2778965386 @default.
• W2562467566 hasConcept C2779026020 @default.
• W2562467566 hasConcept C2911091166 @default.
• W2562467566 hasConcept C55493867 @default.
• W2562467566 hasConcept C555293320 @default.

• next